Castle Biosciences (NASDAQ:CSTL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Castle Biosciences (CSTL) operate in?

Castle Biosciences is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Castle Biosciences Stock (NASDAQ: CSTL) stock price, news, charts, stock research, profile.

Open	$21.27
Close	$21.77
Volume / Avg.	638.22K / 234.53K
Day Range	20.85 - 21.98
52 Wk Range	12.07 - 25.91
Market Cap	$601.01M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	4.25%
Days to Cover	4.39

Recent News

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Avi Kapoor

Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday

U.S. stocks traded lower, with the Dow Jones falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Castle Biosciences Inc

Sector

Health Care

Industry

Health Care Providers & Services

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providi...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Castle Biosciences (CSTL) stock?

You can purchase shares of Castle Biosciences (NASDAQ:CSTL) through any online brokerage.

View our list of the best stock brokerages

Who are Castle Biosciences (CSTL) competitors?

Other companies in Castle Biosciences’s space includes: GeneDx Hldgs (NASDAQ:WGS), Aveanna Healthcare Hldgs (NASDAQ:AVAH), Cross Country Healthcare (NASDAQ:CCRN), Premier (NASDAQ:PINC) and OPKO Health (NASDAQ:OPK).

What is the target price for Castle Biosciences (CSTL) stock?

There is no analysis for Castle Biosciences.

What is the forecast for Castle Biosciences (CSTL) stock?

Castle Biosciences has a consensus price target of $35.09.

Current stock price for Castle Biosciences (CSTL)?

The stock price for Castle Biosciences (NASDAQ: CSTL) is $21.77 last updated June 28, 2024 at 4:04 PM EDT.

Does Castle Biosciences (CSTL) pay a dividend?

There are no upcoming dividends for Castle Biosciences.

When is Castle Biosciences (NASDAQ:CSTL) reporting earnings?

Castle Biosciences’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Is Castle Biosciences (CSTL) going to split?

There is no upcoming split for Castle Biosciences.

What sector and industry does Castle Biosciences (CSTL) operate in?

Castle Biosciences is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Castle Biosciences

Castle Biosciences (CSTL) Forecast